Digital Microfluidics-Enabled Analysis of Individual Variation in Liver Cytochrome P450 Activity

Show full item record



Permalink

http://hdl.handle.net/10138/335623

Citation

Sathyanarayanan , G , Haapala , M & Sikanen , T 2020 , ' Digital Microfluidics-Enabled Analysis of Individual Variation in Liver Cytochrome P450 Activity ' , Analytical Chemistry , vol. 92 , no. 21 , pp. 14693-14701 . https://doi.org/10.1021/acs.analchem.0c03258

Title: Digital Microfluidics-Enabled Analysis of Individual Variation in Liver Cytochrome P450 Activity
Author: Sathyanarayanan, Gowtham; Haapala, Markus; Sikanen, Tiina
Contributor: University of Helsinki, Division of Pharmaceutical Chemistry and Technology
University of Helsinki, Division of Pharmaceutical Chemistry and Technology
University of Helsinki, Drug Research Program
Date: 2020-11-03
Language: eng
Number of pages: 9
Belongs to series: Analytical Chemistry
ISSN: 0003-2700
URI: http://hdl.handle.net/10138/335623
Abstract: The superfamily of hepatic cytochrome P450 (CYP) enzymes is responsible for the intrinsic clearance of the majority of therapeutic drugs in humans. However, the kinetics of drug clearance via CYPs varies significantly among individuals due to both genetic and external factors, and the enzyme amount and function are also largely impacted by many liver diseases. In this study, we developed a new methodology, based on digital microfluidics (DMF), for rapid determination of individual alterations in CYP activity from human-derived liver samples in biopsy-scale. The assay employs human liver microsomes (HLMs), immobilized on magnetic beads to facilitate determination of the activity of microsomal CYP enzymes in a parallelized system at physiological temperature. The thermal control is achieved with the help of a custom-designed, inkjet-printed microheater array modularly integrated with the DMF platform. The CYP activities are determined with the help of prefluorescent, enzyme-selective model compounds by quantifying the respective fluorescent metabolites based on optical readout in situ. The selectivity and sensitivity of the assay was established for four different CYP model reactions, and the diagnostic concept was validated by determining the interindividual variation in one of the four model reaction activities, that is, ethoxyresorufin O-deethylation (CYP1A1/2), between five donors. Overall, the developed protocol consumes only about 15 mu g microsomal protein per assay. It is thus technically adaptable to screening of individual differences in CYP enzyme function from biopsy-scale liver samples in an automated fashion, so as to support tailoring of medical therapies, for example, in the context of liver disease diagnosis.
Subject: 116 Chemical sciences
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
Sathyanarayanan_et_al_Anal_Chem_2020.pdf 1.399Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record